Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 21;10:815596. doi: 10.3389/fcell.2022.815596

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Xu, Lu, Zhao, Wang, Peng and Zhang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Identification of tumor antigens in lung adenocarcinoma that can be used to develop mRNA vaccines (A) The expression of CBFA2T3 is positively correlated with the infiltration of a variety of antigen-presenting cells. (B) The expression of KLRG1 is positively correlated with the infiltration of a variety of antigen-presenting cells. (C) CBFA2T3 and KLRG1 are associated with overall survival and disease-free survival in patients with lung adenocarcinoma. (D–E) Expression of CBFA2T3 and KLRG1 in different stages of patients with lung adenocarcinoma.